US EditionPublished • loading... • Updated
Oncomatryx Will Manufacture Drugs in Gipuzkoa After Transformation Into Biopharmaceutical
Summary by naiz:
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Vizcaina Oncomatryx has completed a capital increase of 58 million euros to move from research company to biopharmaceutical...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
